Print Page   |   Contact Us   |   Your Cart   |   Sign In   |   Register
Community Search


 

 

Sclerotic chronic Graft versus Host Disease
Moderator(s):
Thread Score:
Page 1 of 1
Thread Actions

10/2/2013 at 10:40:51 PM GMT
Posts: 1
Sclerotic chronic Graft versus Host Disease

Dear colleagues,

I have a young patient with chronic GVH disease, sclerotic type, presented with progressing, extensive, painful skin ulcers at torso, arms and legs, with a referral for hyperbaric oxygen therapy.  Biopsy is consistent with fibrosis and GVH, no malignancy. She has been treated with Prednisone (since 1/2011), ECP (d/c 1/2012), sirolimus (d/c 8/2012), imuran (d/c 12/2012), rituximab (d/c 8/2012), tacrolimus (last 5/2013), methotrexate (since 5/2013), IL-2 (since 2/2013). Her primary, diffuse, large B-cell lymphoma seems to be in remission since 2007.

I could not find any data in literature that could give me any information if HBO2T might have any benefit on her case.  I was wondering if you have any insight or knowledge you can share with us on this subject.

Respectfully,

Nilufer Norsworthy, MD

Northwest Hospital, Seattle, WA



10/16/2013 at 3:38:28 PM GMT
Posts: 2
Try a TCOM with O2 challenge?
I have no literature to offer, but would suggest a TCOM with O2 challenge, and then a physician to physician contact with the insurance company.


Sign In


Forgot your password?

Haven't registered yet?

Calendar

12/1/2014
UHMS: Online Wound Care Educational Series

12/1/2014
Hyperbaric Physician Certification